Metraipolis › archive › dc_c30cc6fe014a

How to produce 'marketable and profitable results for the company': from viral interference to Roferon A — Europe PMC PMID:31363860

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/31363860
DOI
10.1007/s40656-019-0268-8
License (as archived)
solo-consultazione
Archived
2026-10-08T05:23:09.892Z
SHA-256 of the archived text
db34f910386ed9c7b30f3fbe39f30877b08dbacb666ed3a5d318358b69c4661e
Stable URL of this page
https://metraipolis.com/documento/dc_c30cc6fe014a

How to cite

How to produce 'marketable and profitable results for the company': from viral interference to Roferon A — Europe PMC PMID:31363860 — Europe PMC (en), https://europepmc.org/article/MED/31363860 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c30cc6fe014a (Metraipolis archive dc_c30cc6fe014a, sha256 db34f910386ed9c7b30f3fbe39f30877b08dbacb666ed3a5d318358b69c4661e)
BibTeX
@misc{dcc30cc6fe014a,
  title = {How to produce 'marketable and profitable results for the company': from viral interference to Roferon A — Europe PMC PMID:31363860},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/31363860},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c30cc6fe014a; sha256 db34f910386ed9c7b30f3fbe39f30877b08dbacb666ed3a5d318358b69c4661e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/31363860. Agents can read the archived copy with the MCP tool read_document.